PRPO Stock Summary and Trading Ideas (Precipio | NASDAQ:PRPO)

Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.

Precipio trades on the NASDAQ stock market under the symbol PRPO.

As of October 28, 2026, PRPO stock price declined to $18.68 with 25,094 million shares trading.

PRPO has a beta of -0.17, meaning it tends to be less sensitive to market movements. PRPO has a correlation of 0.00 to the broad based SPY ETF.

PRPO has a market cap of $33.44 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, PRPO traded as high as $33.63 and as low as $3.90.

The top ETF exchange traded funds that PRPO belongs to (by Net Assets): VTI, VXF, IWC, DFMC, DFAS.

PRPO has underperformed the market in the last year with a price return of -10.4% while the SPY ETF gained +13.8%. PRPO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -18.5% and -17.3%, respectively, while the SPY returned +4.8% and -0.7%, respectively.

PRPO support price is $18.13 and resistance is $19.69 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRPO shares will trade within this expected range on the day.